Table 1.
IgGFc-binding protein (FCGBP) as a prognostic or diagnosis marker for disease.
| Type of disease | Expression state | Function |
|---|---|---|
| Autoimmune diseases | Upregulation | Markers of diagnostic (40) |
| Ovarian carcinoma | Upregulation | Markers of poor prognosis (67) |
| Lower-grade glioma | Upregulation | Markers of poor prognosis (67) |
| HPV-infected HNSCC | Upregulation | Markers of good prognosis (70) |
| Gastric cancer | Upregulation | Participate in the occurrence and development of gastric cancer (69) |
| Premature intraamniotic infection | Upregulation | Biodiagnostic markers (10) |
| HNSCC | Downregulation | Markers of poor prognosis (68) |
| Rectum adenocarcinoma | Downregulation | Markers of poor prognosis (70) |
| Colon adenocarcinoma | Downregulation | Markers of poor prognosis (75) |
| Metastatic colon cancer | Downregulation | Markers of poor prognosis (76) |
| Thyroid cancer | Downregulation | Distinguish between follicular adenomas and follicular carcinomas (71) |
| Prostate cancer | Downregulation | Markers of poor prognosis (74) |
| Gall bladder cancer | Downregulation | Markers of poor prognosis, tools for early detection of gallbladder cancer in benign lesions (14) |